Cargando…

Nongenetic surface engineering of mesenchymal stromal cells with polyvalent antibodies to enhance targeting efficiency

Systemic infusion is a prevalent administration method for mesenchymal stromal cells (MSCs) in clinical trials. However, the inability to deliver a large number of therapeutic cells to diseased tissue is a substantial barrier. Here, we demonstrate that surface engineering of MSCs with polyvalent ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Tenghui, Liu, Xi, Zhong, Xianghua, Yan, Ran, Shi, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509227/
https://www.ncbi.nlm.nih.gov/pubmed/37726299
http://dx.doi.org/10.1038/s41467-023-41609-8